Mori F, Angelucci C, Cianferoni A, Barni S, Indolfi G, Casini A, Mangone G, Materassi M, Pucci N, Azzari C, Novembre E
Allergy Unit, Department of Paediatrics, Anna Meyer Children's University Hospital, Florence, Italy.
Allergy and Immunology Division, Children's Hospital of Philadelphia, PA, USA.
Allergol Immunopathol (Madr). 2018 Sep-Oct;46(5):447-453. doi: 10.1016/j.aller.2017.09.030. Epub 2018 Feb 16.
Transplantation-acquired food allergies (TAFA) are frequently reported and considered to be caused by immunosuppressive therapy. The aim of this study was to investigate the allergic and immunologic responses in children who had liver or kidney transplantations.
Twelve children receiving liver transplantations and 10 children receiving kidney transplantations were investigated. All children underwent the allergy work-up and in most of them, lymphocyte screening and serum cytokine measurements were also performed.
TAFA were found in 7/12 (58%) children with liver transplantations and in none of the 10 children with kidney transplantations. The mean age at transplantation was significantly lower in children who underwent liver transplantations (p<0.001). The immunosuppressive therapy administered to children with liver transplantation was tacrolimus in 11 patients and cyclosporine in one patient, while all 10 children with kidney transplantation received tacrolimus plus mycophenolate. The most common antigenic food was egg. The natural killer (NK) cell numbers were significantly higher in liver-transplant children than in kidney-transplant children. No significant differences were found in the serum cytokine levels.
This study confirms that liver-transplant children treated with tacrolimus alone have a higher risk of developing TAFA than kidney-transplant children treated with tacrolimus plus mycophenolate. NK cells might be involved in this difference.
移植获得性食物过敏(TAFA)经常被报道,并且被认为是由免疫抑制治疗引起的。本研究的目的是调查接受肝移植或肾移植儿童的过敏和免疫反应。
对12名接受肝移植的儿童和10名接受肾移植的儿童进行了调查。所有儿童均接受了过敏检查,并且大多数儿童还进行了淋巴细胞筛查和血清细胞因子检测。
在12名接受肝移植的儿童中有7名(58%)发现了TAFA,而在10名接受肾移植的儿童中均未发现。接受肝移植的儿童移植时的平均年龄显著更低(p<0.001)。接受肝移植的儿童中,11例使用他克莫司,1例使用环孢素进行免疫抑制治疗,而所有10名接受肾移植的儿童均接受他克莫司加霉酚酸酯治疗。最常见的致敏食物是鸡蛋。肝移植儿童的自然杀伤(NK)细胞数量显著高于肾移植儿童。血清细胞因子水平未发现显著差异。
本研究证实,单独使用他克莫司治疗的肝移植儿童发生TAFA的风险高于使用他克莫司加霉酚酸酯治疗的肾移植儿童。NK细胞可能与这种差异有关。